EOLS·30052C107·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
EOLS (EVOLUS INC) is held by 75 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($17.6M), MILLENNIUM MANAGEMENT LLC ($6M), GEODE CAPITAL MANAGEMENT, LLC ($5.7M). Net institutional sentiment: Mixed.
See how EOLS's score breaks down across 4 SEC sources
Showing 1-20 of 92
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer